Six1 mediates resistance to paclitaxel in breast cancer cells
Zhaoming Li(First Affiliated Hospital of Zhengzhou University), Mingzhi Zhang(Chinese Academy of Sciences), Feng Lv(Chinese Academy of Medical Sciences & Peking Union Medical College), Tian Tian(First Affiliated Hospital of Zhengzhou University), Yu Chang(Jilin University), Feifei Nan(First Affiliated Hospital of Zhengzhou University)
Cited by 38
Related Papers
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
|Frontiers in Immunology|2017|296
Acalabrutinib (ACP-196): a selective second-generation BTK inhibitor
|Journal of Hematology & Oncology|2016|250
miR-137 Is Frequently Down-Regulated in Gastric Cancer and Is a Negative Regulator of Cdc42
|Digestive Diseases and Sciences|2011|140
miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy
|Journal of Hematology & Oncology|2018|134